Article
Investigation of Genetic Alterations Associated With Interval Breast Cancer.
JAMA oncology - 1 Mar 2024
Rodriguez Juan, Grassmann Felix, Xiao Qingyang, Eriksson Mikael, Mao Xinhe, Bajalica-Lagercrantz Svetlana, Hall Per, Czene Kamila
Abstract excerpt
Importance: Breast cancers (BCs) diagnosed between 2 screening examinations are called interval cancers (ICs), and they have worse clinicopathological characteristics and poorer prognosis than screen-detected cancers (SDCs). However, the association of rare germline genetic variants with IC have not been studied. Objective: To evaluate whether rare germline deleterious protein-truncating variants (PTVs) can be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
